Clinical Trial Update: NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports the completed early-phase 1 study of NT-I7 (long-acting recombinant interleukin-7) as an immune reconstitution strategy for l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• NT-I7

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Progressive Multifocal Leukoencephalopathy | EARLY_Phase 1 | Status: COMPLETED